E-LIB Suche - Ergebnisse für: Sugimoto, Takeya

1

Mannitol versus furosemide in patients with thoracic malign..:

Murakami, Eriko ; Akamatsu, Hiroaki ; Teraoka, Shunsuke...
Cancer Medicine. 13 (2024) 4 - p. , 2024

2

A Phase II Study of High-Flow Nasal Cannula for Relieving D..:

Takase, Eri ; Akamatsu, Hiroaki ; Teraoka, Shunsuke...
Journal of Pain and Symptom Management. 67 (2024) 3 - p. 204-211.e1 , 2024

Link: https://doi.org/10.1016/..

3

Prospective multicenter cohort study of durvalumab for pati..:

Sugimoto, Takeya ; Fujimoto, Daichi ; Sato, Yuki...
Lung Cancer. 171 (2022) - p. 3-8 , 2022

Link: https://doi.org/10.1016/..

4

Impact of pre‐existing interstitial lung abnormal shadow on..:

Shibaki, Ryota ; Ozawa, Yuichi ; Noguchi, Susumu...
Cancer Medicine. 11 (2022) 20 - p. 3743-3750 , 2022

Link: https://doi.org/10.1002/..

5

Pre-treatment serum protein levels predict survival of non-..:

Harutani, Yuhei ; Ozawa, Yuichi ; Murakami, Eriko...
Cancer Immunology, Immunotherapy. 71 (2022) 9 - p. 2109-2116 , 2022

Link: https://doi.org/10.1007/..

6

Durvalumab for patients with unresectable stage III non-sma..:

Sugimoto, Takeya ; Fujimoto, Daichi ; Sato, Yuki...
Investigational New Drugs. 39 (2021) 3 - p. 853-859 , 2021

Link: https://doi.org/10.1007/..

7

CD24, not CD47, negatively impacts upon response to PD‐1/L1..:

Ozawa, Yuichi ; Harutani, Yuhei ; Oyanagi, Jun...
Cancer Science. 112 (2020) 1 - p. 72-80 , 2020

Link: https://doi.org/10.1111/..

8

Prospective, multicentre, single-arm phase II trial of pemb..:

Ozawa, Yuichi ; Sugimoto, Takeya ; Azuma, Yuichiro...
BMJ Open. 10 (2020) 7 - p. e037746 , 2020

Link: https://doi.org/10.1136/..

9

Immune-Related Adverse Events by Immune Checkpoint Inhibito..:

Akamatsu, Hiroaki ; Murakami, Eriko ; Oyanagi, Jun...
The Oncologist. 25 (2019) 4 - p. e679-e683 , 2019

Link: https://doi.org/10.1634/..

10

Osimertinib for patients with EGFR T790M mutation-positive ..:

Nakashima, Kazuhisa ; Kimura, Madoka ; Akamatsu, Hiroaki...
Japanese Journal of Clinical Oncology. 49 (2019) 7 - p. 671-675 , 2019

Link: https://doi.org/10.1093/..

11

Prospective, multicentre, single-arm phase II trial of pemb..:

Ozawa, Yuichi ; Sugimoto, Takeya ; Azuma, Yuichiro...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375432/. , 2020

Link: http://www.ncbi.nlm.nih...

12

Immune‐Related Adverse Events by Immune Checkpoint Inhibito..:

Akamatsu, Hiroaki ; Murakami, Eriko ; Oyanagi, Jun...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160399/. , 2019

Link: http://www.ncbi.nlm.nih...

13

Impact of pre‐existing interstitial lung abnormal shadow on..:

Ryota Shibaki ; Yuichi Ozawa ; Susumu Noguchi...
https://doi.org/10.1002/cam4.4750. , 2022

Link: https://doi.org/10.1002/..

14

Prospective, multicentre, single-arm phase II trial of pemb..:

Nobuyuki Yamamoto ; Yuichi Ozawa ; Takeya Sugimoto...
https://bmjopen.bmj.com/content/10/7/e037746.full. , 2020

Link: https://doi.org/10.1136/..

15

Single and Repeated Dose 28-Day and 13-Week Toxicity Studie..:

Sugimoto, Koki ; Tanizaki, Toshifumi ; Shimizu, Eito...
Foods. 9 (2020) 6 - p. 691 , 2020

Link: https://doi.org/10.3390/..